Clinical Trial Update: Economic Evaluation of New MDR TB Regimens [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the economic aspects of new regimens for multidrug-resistant and extensively drug-resistant tuberculosis across Phase 2 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis

Snippet

Sponsor: Medecins Sans Frontieres, Netherlands | Conditions: Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED